Clinical efficacy of complex therapy in patients with chronic pancreatitis and atherosclerosis using ursodeoxycholic acid and high doses of substitute therapy with pancreatic enzymes
The results are presented and the efcacy of prescribing ursodeoxy-cholic acid and high doses of replacement therapy with pancreatic enzymes for clinical and laboratory indicators in patients with chronic pancreatitis and atherosclerosis is analyzed. The positive effect of the drug UDCA at a dose of 15 mg/kg of body weight for 3 months and high doses of substitution therapy with Pangrol 25 000, 2 capsules 3 times per day for symptoms of diseases, lipid profile, 13C-amylase and 13C-mixed triglyceride breathing tests in these patients.